Be a part of 5^th International Meeting on Breast Cancer & Therapies

Understanding the genetic and molecular underpinnings of breast cancer is vital for precision medicine. Advances in genomics, transcriptomics, and epigenetics are unraveling how BRCA1/2 mutations, HER2 amplification, and other molecular markers drive cancer progression. Multi-omics approaches are offering insights into tumor heterogeneity, enabling tailored therapies. This track focuses on molecular pathways, tumor biology, and gene-environment interactions to better stratify risk and personalize treatment.

• Track 2-1: BRCA Mutations & Genetic Counseling
• Track 2-2: Epigenetics & Gene Regulation
• Track 2-3: Predictive & Prognostic Biomarkers

TNBC remains one of the most aggressive subtypes, characterized by poor prognosis and limited treatment options. Research is advancing in targeted therapies, immune checkpoint inhibitors, and biomarker-driven clinical trials. This track will address novel therapeutic strategies, mechanisms of resistance, and how precision medicine is opening doors for TNBC management.

• Track 3-1: Molecular Subtypes of TNBC
• Track 3-2: Targeted Therapy & PARP Inhibitors
• Track 3-3: Immunotherapy & Immune Checkpoint Inhibitors

Tailoring treatment to individual patients is transforming care outcomes. Liquid biopsy, molecular profiling, and AI-driven predictive models allow clinicians to design highly personalized treatment plans. This track emphasizes the role of personalized medicine in early detection, therapy selection, and relapse prevention

• Track 4-1: Molecular Profiling & Tumor Sequencing
• Track 4-2: AI & Predictive Analytics in Oncology
• Track 4-3: Pharmacogenomics in Breast Cancer Therapy

Conventional treatments such as surgery, radiation, chemotherapy, and endocrine therapy are being complemented by innovative therapies. This track will explore new strategies, combination therapies, and advances in reducing toxicity while maintaining efficacy.

• Track 5-1: Advances in Chemotherapy & Endocrine Therapy
• Track 5-2: Targeted Therapy Combinations
• Track 5-3: Nanomedicine & Drug Delivery Systems

The immune system plays a central role in controlling tumor growth. Immunotherapy, especially immune checkpoint inhibitors, has shown promise in breast cancer management. This track explores novel immune targets, combination therapies, and the future of immuno-oncology.

• Track 6-1: Immune Checkpoint Inhibitors (PD-1/PD-L1, CTLA-4)
• Track 6-2: CAR-T Cell Therapy in Breast Cancer
• Track 6-3: Immunotherapy in TNBC

Surgery continues to be a cornerstone of treatment. Oncoplastic and minimally invasive techniques are improving cosmetic and functional outcomes. This track focuses on the role of sentinel lymph node biopsy, breast reconstruction, and innovative surgical technologies.

• Track 7-1: Oncoplastic Breast Surgery
• Track 7-2: Minimally Invasive & Robotic Techniques
• Track 7-3: Sentinel Lymph Node Biopsy & Axillary Surgery

Modern radiation therapy techniques offer precise tumor targeting while sparing healthy tissue. Hypofractionation, proton therapy, and adaptive radiation are improving outcomes. This track examines innovations in radiation oncology and their clinical impact.

• Track 8-1: Hypofractionation in Breast Cancer
• Track 8-2: Proton Therapy & Advanced Modalities
• Track 8-3: Radiotherapy for Recurrent & Metastatic Disease

Clinical trials bridge the gap between laboratory discoveries and clinical practice. This track will cover trial design, novel endpoints, translational research, and global collaboration to bring therapies from bench to bedside.

• Track 9-1: Innovative Clinical Trial Designs
• Track 9-2: Biomarker-Driven Studies
• Track 9-3: Translational Oncology & Bench-to-Bedside Research

Metastatic breast cancer remains a leading cause of mortality. Advances in systemic therapy, palliative care, and molecular profiling are improving survival and quality of life. This track highlights strategies for managing metastases and emerging therapies.

• Track 10-1: Bone, Brain, & Visceral Metastases
• Track 10-2: Targeted & Systemic Therapies for MBC
• Track 10-3: Biomarkers of Disease Progression

Prevention remains the most effective strategy to reduce global burden. This track will discuss lifestyle interventions, chemoprevention, and genetic counseling in reducing risk across populations.

As survival rates improve, long-term survivorship issues gain importance. This track will address physical, emotional, and social aspects of survivorship, rehabilitation, and integrative medicine to support holistic care.

• Track 12-1: Mental Health & Psychosocial Support
• Track 12-2: Rehabilitation & Physical Activity
• Track 12-3: Mental Health & Psychosocial Support

Breast cancer presents unique challenges in men, younger women, and during pregnancy. This track explores clinical and psychosocial considerations for special populations.

• Track 13-1: Male Breast Cancer
• Track 13-2: Pregnancy-Associated Breast Cancer
• Track 13-3: Geriatric Breast Cancer Care

Despite medical advances, access to care remains uneven globally. This track addresses health disparities, affordability, and strategies for equity in breast cancer prevention and treatment.